These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31092343)

  • 21. Preparation, transfer for commercial distribution, and use of byproduct material for medical use--NRC. Final rule; clarification.
    Fed Regist; 1995 Jan; 60(2 Pt 1):322-5. PubMed ID: 10139994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NRC proposed amendments: too little, too late?
    Newman MA
    J Nucl Med; 1993 Sep; 34(9):25N. PubMed ID: 8355088
    [No Abstract]   [Full Text] [Related]  

  • 23. Understanding patient needs: congressmen aid nuclear medicine.
    Kotz D
    J Nucl Med; 1998 Nov; 39(11):16N, 21N-22N, 30N. PubMed ID: 9829563
    [No Abstract]   [Full Text] [Related]  

  • 24. [Authorized specifications for human use in clinical practice of radiopharmaceuticals composed of iobenguane (123I) marketed in Spain].
    Cortés-Blanco A; Martínez Lázaro R; Vargas Castrillón E
    Rev Esp Med Nucl; 2008; 27(6):468-74. PubMed ID: 19094909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical use of byproduct material; public meetings--NRC. Notice of public meetings.
    Fed Regist; 1998 Jul; 63(142):39763-5. PubMed ID: 10181515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear medicine/radiology training and certification requirements recent changes.
    Harolds J; Graham MM; Maurer A; Guiberteau MJ; Miller TR; Vydareny K
    Acad Radiol; 2006 Nov; 13(11):1405-9. PubMed ID: 17070459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. US NRC discussion of options to revise radiation protection recommendations.
    Cool DA
    Ann ICRP; 2012; 41(3-4):313-7. PubMed ID: 23089031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exempt distribution of a radioactive drug containing one microcurie of carbon-14 urea--NRC. Final rule.
    Fed Regist; 1997 Dec; 62(231):63634-40. PubMed ID: 10176576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procedure guideline for the use of radiopharmaceuticals 4.0.
    Callahan RJ; Chilton HM; Ponto JA; Swanson DP; Royal HD; Bruce AD
    J Nucl Med Technol; 2007 Dec; 35(4):272-5. PubMed ID: 18006598
    [No Abstract]   [Full Text] [Related]  

  • 30. Looking ahead to government regulation and response in nuclear medicine.
    Uffelman W
    J Nucl Med; 2001 Jan; 42(1):21N-22N. PubMed ID: 11197974
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulations for radioiodine therapy in the United States: current status and the process of change.
    Vetter RJ
    Thyroid; 1997 Apr; 7(2):209-11. PubMed ID: 9133686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The directive is now here. Are we ready?
    de Haro Del Moral FJ; Barquero R
    Rev Esp Med Nucl Imagen Mol; 2017; 36(3):137-138. PubMed ID: 28330598
    [No Abstract]   [Full Text] [Related]  

  • 33. Operation of a radiopharmacy for a clinical trial.
    Norenberg JP; Petry NA; Schwarz S
    Semin Nucl Med; 2010 Sep; 40(5):347-56. PubMed ID: 20674594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation protection and regulations for the nuclear medicine physician.
    Chen MY
    Semin Nucl Med; 2014 May; 44(3):215-28. PubMed ID: 24832587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NRC simplifies regulations for medical use of byproduct material (10 CFR Part 35).
    Frohman JE
    J Nucl Med; 1987 Feb; 28(2):151-3. PubMed ID: 3806218
    [No Abstract]   [Full Text] [Related]  

  • 36. Occupational Dose and Dose Limits: Experience in a Large Multisite Hospital System.
    Sensakovic WF; Flores M; Hough M
    J Am Coll Radiol; 2016 Jun; 13(6):649-55. PubMed ID: 27033162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. USP General Chapter <825> Impact on Nuclear Medicine Technology Practice.
    Hinkle GH
    J Nucl Med Technol; 2020 Jun; 48(2):106-113. PubMed ID: 32499321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive quality assurance in medical use and a standard of care--NRC. Advance notice of proposed rulemaking: withdrawal.
    Fed Regist; 1998 Dec; 63(231):66496. PubMed ID: 10338878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited revision of fee schedules--NRC. Final rule.
    Fed Regist; 1992 Apr; 57(75):13625-34. PubMed ID: 10118460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear medicine affected by Energy Policy Act of 2005.
    J Nucl Med; 2005 Oct; 46(10):12N, 14N. PubMed ID: 16312055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.